HB Wealth Management LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.4% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 48,952 shares of the healthcare conglomerate's stock after selling 15,828 shares during the period. HB Wealth Management LLC's holdings in UnitedHealth Group were worth $15,272,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently bought and sold shares of UNH. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its holdings in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Baker Tilly Wealth Management LLC grew its holdings in UnitedHealth Group by 5.4% during the first quarter. Baker Tilly Wealth Management LLC now owns 1,276 shares of the healthcare conglomerate's stock worth $668,000 after purchasing an additional 65 shares during the period. Fiduciary Alliance LLC grew its holdings in UnitedHealth Group by 2.8% during the first quarter. Fiduciary Alliance LLC now owns 10,172 shares of the healthcare conglomerate's stock worth $5,328,000 after purchasing an additional 279 shares during the period. Finally, NBC Securities Inc. grew its holdings in UnitedHealth Group by 71,127.3% during the first quarter. NBC Securities Inc. now owns 7,835 shares of the healthcare conglomerate's stock worth $4,103,000 after purchasing an additional 7,824 shares during the period. 87.86% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on UNH. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Bank of America boosted their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Truist Financial boosted their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a report on Tuesday, September 9th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $358.95.
Get Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Stock Up 0.2%
Shares of UNH opened at $344.61 on Tuesday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a market cap of $312.10 billion, a P/E ratio of 14.93, a P/E/G ratio of 2.24 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a 50 day simple moving average of $302.45 and a two-hundred day simple moving average of $357.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio is 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.